The enteric disease testing market is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The increasing food demand has compelled farmers, food manufacturers, and suppliers to increase the quantity and improve the quality of agricultural produce and food products. To meet the increasing food demand, global food production must increase by 70% by 2050, according to the Food and Agriculture Organization of the United Nations (FAO). The increase in global food production impacts the growth of the enteric disease testing market, with an increasing number of enteric disease controls in each step—from raw material procurement until the product reaches consumers, who look out for accredited certification when they purchase food products to ensure the safety of food.
Enteric Disease Testing Market Driver: Increase in demand for convenience foods
Busy lifestyles have slowly shifted consumer focus from traditional buying of raw food products to convenience and packaged food products, such as frozen foods and ready-to-eat (RTE) meals. For higher marketability, additives are used to enhance the organoleptic characteristics of food & beverages. Packaged products are also treated with preservatives to improve their shelf life.
The meat, poultry, and seafood food sub-segment is estimated to account for the largest market share in the food end-use segment of the enteric disease testing market over the forecast period.
The global consumption of meat and processed meat products is highly rising. Further, with expanding globalization, food products are traded, which provides scope for various processes ranging from packaging, handling, storing and transportation, leading to food infestation. All these factors lead to an increased chance of contamination of the food, due to which meat and seafood products are estimated to account for the highest market share in the market.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139763313
Europe is projected to be the fastest-growing market for the forecast period.
The market in this region is primarily driven by growth in the German and UK markets. It is also driven by European food policies that have been extensively emphasized by the National Reference Laboratories (NRLs) and the European Reference Laboratories (EURLs) to maintain food standards and protect consumer health. Campylobacter has been the most commonly reported food outbreak, with an increase in confirmed human cases in the European Union (EU). The market is further fueled by the presence of major enteric disease testing companies such as SGS SA (Switzerland), Eurofins Scientific (Luxembourg), and Intertek Group plc (UK), which are continuously investing and collaborating for the development of better and faster testing technologies to aid conformity to various enteric disease regulations.
Enteric Disease Testing Market Share
Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Bureau Veritas (France), Intertek (UK), Romer Labs (Austria), Mérieux NutriSciences (US), TÜV SÜD (Germany), PerkinElmer, Inc. (US), Becton Dickinson (US), Certified Laboratories (US), ALS Limited (Australia), Neogen Corporation (US), Hardy Diagnostics (US)
